Top compounds associated with response to SLF2


Feature Type Standardized
Nominal ANOVA
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA FK866 GDSC1000 pan-cancer AAC 0.095 0.002
mRNA clofarabine CTRPv2 pan-cancer AAC 0.09 0.003
mRNA Crizotinib GDSC1000 pan-cancer AAC 0.16 0.003
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.097 0.003
mRNA brivanib CTRPv2 pan-cancer AAC 0.11 0.003
mRNA compound 1B CTRPv2 pan-cancer AAC -0.11 0.003
mRNA barasertib CTRPv2 pan-cancer AAC 0.096 0.004
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.004
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.1 0.004
Download CSV